00:48 , Jul 26, 2019 |  BC Innovations  |  Product Development

Institute for Protein Design's de novo revolution

Seattle's Institute for Protein Design is growing an army of spinouts that build proteins from the ground up. With applications ranging from multivalent vaccines and synthetic cytokines to precision cell therapies, these companies could put...
00:09 , Jun 21, 2019 |  BC Extra  |  Financial News

June 20 Financial Quick Takes: Zymeworks raises $175M; plus Casdin, Scholar Rock and more

Zymeworks trades up after follow-on  Zymeworks Inc. (NYSE:ZYME; TSX:ZYME) added $1.74 (10%) to $20.05 Thursday after raising $175 million late Wednesday through the sale of 9.7 million shares at $18 in a follow-on. The price...
19:58 , Sep 21, 2017 |  BC Innovations  |  Tools & Techniques

On your marks

With less fanfare than the first two waves, a quiet rise in activity is driving a revival of interest in epigenetics, despite little progress in solving the fundamental challenges that have dogged the field from...
08:00 , Jan 18, 2016 |  BC Week In Review  |  Financial News

Syros completes venture financing

Syros Pharmaceuticals Inc. , Watertown, Mass.   Business: Cancer, Genomics   Date completed: 2016-01-12   Type: Venture financing   Raised: $40 million   Investors: Deerfield Management; Casdin Capital LLC; Fidelity; WuXi Healthcare Ventures; Polaris Partners;...
07:00 , Oct 26, 2015 |  BC Week In Review  |  Financial News

Gritstone Oncology completes venture financing

Gritstone Oncology Inc. , Emeryville, Calif.   Business: Cancer   Date completed: 2015-10-20   Type: Venture financing   Raised: $102 million   Investors: Versant Ventures ; The Column Group; Clarus Ventures; Frazier Healthcare; Redmile Group;...
07:00 , Jun 22, 2015 |  BC Week In Review  |  Financial News

CytomX completes venture financing

CytomX Therapeutics Inc. , South San Francisco, Calif.   Business: Antibodies, Cancer, Autoimmune   Date completed: 2015-06-16   Type: Venture financing   Raised: $70 million   Investors: Fidelity; Casdin Capital LLC; Cormorant Asset Management; Deerfield...
07:00 , May 11, 2015 |  BC Week In Review  |  Financial News

Adaptive Biotechnologies completes venture financing

Adaptive Biotechnologies Corp. , Seattle, Wash.   Business: Bioinformatics, Diagnostic, High throughput screening   Date completed: 2015-05-06   Type: Venture financing   Raised: $195 million   Investors: Matrix Capital Management; Senator Investment Group; Tiger Management;...
07:00 , May 4, 2015 |  BC Week In Review  |  Financial News

MyoKardia completes venture financing

MyoKardia Inc. , San Francisco, Calif.   Business: Cardiovascular   Date completed: 2015-04-30   Type: Venture financing   Raised: $46 million   Investors: Casdin Capital LLC; Cormorant Asset Management; Perceptive Life Sciences Fund; BridgeBio; Sanofi...
07:00 , Apr 27, 2015 |  BC Week In Review  |  Financial News

Jounce Therapeutics completes venture financing

Jounce Therapeutics Inc. , Cambridge, Mass.   Business: Cancer   Date completed: 2015-04-23   Type: Venture financing   Raised: $56 million   Investors: Wellington Management; Redmile Group; Nextech Invest; Pharmstandard International S.A.; Cormorant Asset Management;...
07:00 , Apr 20, 2015 |  BC Week In Review  |  Financial News

Voyager Therapeutics completes venture financing

Voyager Therapeutics Inc. , Cambridge, Mass.   Business: Neurology, Gene/Cell therapy   Date completed: 2015-04-13   Type: Venture financing   Raised: $60 million   Investors: Brookside Capital; Partner Fund Management; Wellington Management; Casdin Capital LLC;...